1. Australia Stocks

  2. •

    Healthcare

  3. •

    Conglomerates
Beroni Group Limited

Beroni Group Limited

BNIGF
Beroni Group LimitedUS flagOther OTC
0.01
USD
- -
- -
212,760.00Market Cap
Beroni Group Limited
BNIGF
(Other OTC)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
FRC
0.24
0.18
0.13
0.1
0.1
0.12
0.03
0.02
Revenue per Share
0.03
-0.06
-0.15
-0.44
-0.52
-0.14
-0.42
-0.47
Basic EPS, GAAP
0.07
-0.14
-0.31
- -
- -
- -
-0.05
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.13
0.83
1.1
0.76
0.35
0.44
0.01
-0.49
Book Value per Share
0.12
0.84
1.03
0.66
0.23
0.26
0.23
-0.16
Tangible Book Value per Share
18
13
16
18
19
19
19
20
Basic Weighted Avg Shares
4
2
2
2
2
2
1
- -
Sales/Revenue/Turnover
14.57
-27.25
-112.37
-302.17
-282.34
-145.41
-1,277.1
-1,200.1
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
-2
-8
-10
-3
-8
-9
Net Income, GAAP
25.58
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
10.91
-31.65
-112.21
-457.58
-544.3
-121.24
-1,263.03
-1,968.54
Profit Margin (%)
2
11
13
9
2
4
3
-4
Working Capital
- -
- -
- -
1
- -
- -
1
- -
LT Debt
2
11
18
13
8
8
8
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-11.08
-16.86
-49.25
-97.78
-36.18
-191.77
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-33.92%
-100%
Free Cash Flow
- -
1,010.37%
-99.42%
Net Income, GAAP
- -
78.02%
14.34%
Sales/Revenue/Turnover
- -
-18.2%
-26.64%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
1
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-0.42
2023
- -
- -
- -
- -
-0.47
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
CJ Corporation (001040.KS)
Shashwat Furnishing Solutions Ltd. (SFSL.BO)
Grupo Carso, S.A.B. de C.V. (GPOVF)
Kurabo Industries Ltd. (3106.T)
Sanistål A/S (SANI.CO)
Tsuzuki Denki Co., Ltd. (8157.T)
Business
Beroni Group Limited (BNIGF) is a technology company focused on developing and providing innovative solutions in the digital asset and blockchain sectors. The company offers core products and services including cryptocurrency mining operations, blockchain infrastructure platforms, digital wallet technologies, and related fintech services such as secure transaction processing and asset management tools. Its offerings target institutional investors, retail users, and enterprises seeking scalable blockchain applications, with operations spanning North America, Europe, and Asia. Founded in 2018 and headquartered in Vancouver, Canada, Beroni Group emphasizes sustainable mining practices and integration of artificial intelligence for optimized performance. In the past year, the company completed a strategic acquisition of a European blockchain startup to expand its hardware capabilities, launched a new line of energy-efficient mining rigs under the Beroni Tech brand, and formed a partnership with a major renewable energy provider to enhance its green credentials amid industry shifts toward sustainability.

Company News

APIChatGPT

  • globenewswire.com

    Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

  • globenewswire.com

    Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans

  • globenewswire.com

    Beroni Group's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

  • globenewswire.com

    Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company